Skip to main content
Intercure Ltd. logo

Intercure Ltd. — Investor Relations & Filings

Ticker · INCR ISIN · IL0011063760 LEI · 549300KI5ESXF8F5GP06 TA Manufacturing
Open in API
Filings indexed 334 across all filing types
Latest filing 2021-11-29 Board/Management Inform…
Country IL Israel
Listing TA INCR

About Intercure Ltd.

https://www.intercure.co

Intercure Ltd. is a company focused on the production and distribution of pharmaceutical-grade medical cannabis and cannabis-based products. Operating primarily through its wholly-owned subsidiary, Canndoc Ltd., the company is a licensed producer of Good Manufacturing Practice (GMP) certified medical cannabis. Intercure's strategy involves international expansion through strategic partnerships, such as producing and distributing established brands like Cookies in European markets, and through acquisitions to access premium technologies and brands. The company leverages its EU-GMP certified manufacturing facilities to supply its products for medical use across its operational territories.

Recent filings

Filing Released Lang Actions
Immediate Report of Meeting to be held on December 30, 2021,proxy-amendment
Board/Management Information Classification · 1% confidence The document consists of multiple declarations in Hebrew, specifically titled 'Declaration of a candidate for external director in a public company in accordance with the provisions of the Companies Law, 1999' and 'Declaration for the examination of a director as having accounting and financial expertise and/or professional qualification'. These forms are used by individuals being nominated or appointed as directors (specifically external directors) to confirm their qualifications, independence, and lack of conflicts of interest, as required by Israeli corporate law (Companies Law and related regulations). This type of document relates directly to the composition and qualifications of the Board of Directors/Management. Therefore, it falls under the category of Board/Management Information (MANG).
2021-11-29 Hebrew (modern)
Immediate Report of Meeting to be held on December 30, 2021,proxy-amendment
Proxy Solicitation & Information Statement Classification · 1% confidence The document is explicitly titled 'Appointment of Proxyholder' and 'Proxy Form – Extraordinary General Meeting of Shareholders of Intercure Ltd.' It details instructions for shareholders on how to appoint a proxy to vote on specific resolutions (re-election of directors) at an upcoming Extraordinary General Meeting (EGM) scheduled for December 30, 2021. This material is used to solicit shareholder votes ahead of a meeting, which aligns perfectly with the definition of Proxy Solicitation & Information Statement (PSI). It is not the AGM presentation itself (AGM-R), nor is it a general information circular (which would be closer to DEF 14A or CGR, but PSI is more specific for proxy voting materials).
2021-11-29 English
Immediate Report of Meeting to be held on December 30, 2021,proxy-amendment
Proxy Solicitation & Information Statement Classification · 1% confidence The document is explicitly titled 'MANAGEMENT INFORMATION CIRCULAR FOR AN EXTRAORDINARY GENERAL MEETING OF SHAREHOLDERS TO BE HELD ON DECEMBER 30, 2021'. It solicits proxies for an Extraordinary General Meeting (EGM) and details the voting procedures and proposals (re-election of directors). A Management Information Circular (MIC) in Canadian/Israeli contexts, especially when soliciting proxies for a meeting, is the primary document used to provide information to shareholders ahead of a vote. This aligns directly with the definition of Proxy Solicitation & Information Statement (PSI). Although it relates to an AGM/EGM, the core function described is the solicitation of proxies and providing the necessary information for that vote, making PSI the most precise fit over AGM-R (which is usually the presentation/materials *from* the meeting itself).
2021-11-29 English
Immediate Report of Meeting to be held on December 30, 2021,proxy-amendment
AGM Information Classification · 1% confidence The document explicitly states it is an 'Amended report for distorted report sent on date *25/11/2021*' concerning the 'convening of meeting *extraordinary meeting*'. It details the date, time, location, and agenda items for this meeting, which involve re-electing directors. This content is characteristic of a formal notice sent to shareholders regarding a general meeting, often preceding the actual voting results. The presence of agenda items, voting details, and references to proxy forms strongly suggests this is related to the Annual General Meeting (AGM) process or a similar shareholder meeting notification. Since it is a notice convening a meeting with specific agenda items for shareholder vote, the most appropriate classification is AGM-R (AGM Information), as it pertains directly to the materials and notice for the general meeting.
2021-11-29 English
InterCure to Participate in Cowen’s 4th Annual Cannabis Conference
Regulatory Filings Classification · 1% confidence The document is a press release from InterCure Ltd. announcing that its CEO will participate in the 'Cowen's 4th Annual Cannabis Conference'. It details the date and time of the panel participation and provides contact information for scheduling one-on-one meetings. This type of announcement, which informs investors about management's participation in industry events, does not fit the definitions for formal financial reports (10-K, IR, ER, AR) or specific corporate actions (DIV, SHA, POS). It is a general corporate update related to investor relations and market visibility. Since it is a specific announcement about management's engagement at an external event, it is best classified as a general Regulatory Filing (RNS) as it is a broad communication to the market that doesn't fit the more specific categories like Director's Dealing (DIRS) or Earnings Release (ER). Given the context of management engagement, it could potentially be related to Investor Presentation (IP) materials if the presentation itself was attached, but here it is only an announcement of attendance. RNS is the most appropriate fallback for general corporate news releases not covered elsewhere.
2021-11-29 English
InterCure to Participate in Cowen’s 4th Annual Cannabis Conference
Report Publication Announcement Classification · 1% confidence The document is very short (1792 characters) and explicitly states, "Attached hereto is a report on *report_isa.pdf*". This structure indicates that the document itself is an announcement about the availability of another report, rather than the full report content. It is filed under 'Immediate Report' regulations for a foreign corporation with the Israel Securities Authority and the Tel Aviv Stock Exchange. Since it is an announcement of a report's publication and does not fit specific categories like ER, 10-K, or IR, it best matches the Report Publication Announcement (RPA) category, which covers announcements regarding the release of company reports.
2021-11-29 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.